Biggest News Aggregation in the World
📰 Infrastructure Ahead News

Infrastructure Ahead News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Infrastructure Ahead. Real-time updates on events, politics, business and more.

Tonix Pharmaceuticals Enters into Agreement to Acquire Two FDA-Approved, Marketed Migraine Products from Upsher-Smith Laboratories, LLC - Tonix Pharmaceuticals (NASDAQ:TNXP)

Zembrace® SymTouch® (sumatriptan injection) and Tosymra® (sumatriptan nasal spray) are Indicated for the Treatment of Acute Migraine in Adults Strategic Acquisition Helps Build Tonix's Commercial
United States Peter Vozzo Ben Shannon Gregory Sullivan James Hunter Zembrace Symtouch

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science